（文章来源：证券日报） 证券日报网讯新里程8月6日在互动平台回答投资者提问时表示，截至2025年7月31日收盘，公司股东人 数为67112户。 ...

Core Insights - As of August 5, a total of 116 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for five consecutive days or more [1] - The stocks with the longest consecutive net inflow days are Huicheng Environmental Protection and Chengdi Xiangjiang, both achieving 17 consecutive trading days of net inflows [1] - Other notable stocks with significant consecutive net inflow days include Gaomei Co., Juhe Materials, China Baoan, Langkun Technology, Jichuan Pharmaceutical, Jiuri New Materials, Xinlicheng, Cangge Mining, Tianzhihang, and Jingcheng Co., with inflow days ranging from 9 to 15 [1]

Group 1 - A total of 107 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for 5 consecutive days or more as of August 4 [1] - The stocks with the longest consecutive net inflows are Chengdi Xiangjiang and Huicheng Environmental Protection, both achieving 16 consecutive trading days of net inflows [1] - Other notable stocks with significant consecutive net inflows include Gaocai Co., Ltd. (14 days), Juhe Materials (13 days), Juchen Co., Ltd. (12 days), China Baoan (10 days), Hongrun Construction (9 days), Jiurichuang New Materials (9 days), New Mileage (9 days), Jichuan Pharmaceutical (9 days), and Langkun Technology (9 days) [1]

Core Viewpoint - New Mile's stock closed at 2.18 yuan on August 4, down 1.80%, with a rolling PE ratio of 65.86 times and a total market value of 7.384 billion yuan [1] Group 1: Company Overview - New Mile Health Technology Group Co., Ltd. specializes in medical services and pharmaceutical manufacturing, focusing on drug production for over 20 years [1] - The company's main products include pharmaceuticals and medical services, with the "Duyiwei" brand as its core series of traditional Chinese medicine [1] - "Duyiwei Capsule" is included in the 2020 edition of the "Chinese Pharmacopoeia" and is recognized as a national basic drug, featuring unique efficacy, high safety, and low treatment costs [1] Group 2: Financial Performance - In the first quarter of 2025, the company reported operating revenue of 796 million yuan, a year-on-year decrease of 16.49%, and a net profit of 25.652 million yuan, down 9.35% year-on-year, with a gross profit margin of 27.96% [1] Group 3: Industry Comparison - The average PE ratio for the medical services industry is 47.79 times, with a median of 59.03 times, placing New Mile at the 32nd position in the industry ranking [2] - The company's static PE ratio is 64.34 times, and its price-to-book ratio is 3.66 times [2]

证券之星消息，8月4日医疗服务板块较上一交易日下跌0.26%，昭衍新药领跌。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 688265 | 南模生物 | 43.73 | 20.01% | | 4.08万 | 1.66亿 | | 688621 | 阳光诺和 | 66.54 | 14.84% | | 12.60万 | 8.15亿 | | 301201 | 诚达药业 | 28.10 | 4.04% | | 10.58万 | 2.93亿 | | 688222 | 成都先导 | 24.74 | 3.82% | | 33.55万 | 7.91亿 | | 002172 | 澳洋健康 | 4.25 | 3.41% | | 70.07万 | 2.93亿 | | 688046 | 药康生物 | 16.41 | 3.01% | | 4.55万 | 7293.23万 | | ...

Core Insights - As of the last trading day on August 1, the pledge ratio of New Mile shareholders accounts for 14.36% of the total share capital, ranking 631st in the two markets [1] - New Mile shareholders have pledged a total of 487 million shares across 13 transactions, with a total market value of 1.08 billion yuan [1] - New Mile Health Technology Group Co., Ltd. specializes in medical services and pharmaceutical manufacturing, focusing on traditional Chinese medicine with its core brand "Duyiwei" [1] - The "Duyiwei Capsule" is included in the 2020 edition of the Chinese Pharmacopoeia and is recognized as a national essential medicine, featuring unique efficacy, high safety, and low treatment costs [1] - The "Duyiwei" trademark is recognized as a famous Chinese trademark [1] - The chairman of the company is Xu Minggui [1] - Over the past year, New Mile's stock has increased by 24.02% [1]

000558 天府文旅 B004 000826 启迪环境 B001 000998 隆平高科 B001 001236 弘业期货 A07 001314 亿道信息 A06 001324 长青科技 A06 002037 保利联合 A06 002198 嘉应制药 A07 002219 新里程 B001 002330 得利斯 B007 002408 齐翔腾达 B003 002424 贵州百灵 A07 002600 领益智造 B007 002629 仁智股份 A07 002634 棒杰股份 A07 002716 湖南白银 A06 002775 文科股份 B004 002799 环球印务 A07 002921 联诚精密 A07 002940 昂利康 B004 002951 金时科技 A06 300691 联合光电 A06 301632 广东建科 A08 600009 上海机场 A08 600031 三一重工 A08 600104 上汽集团 A08 600166 福田汽车 B003 600507 方大特钢 B001 平安基金 B003 融通基金 B007 上银基金 B005 天弘基金 B006 太平基金 B005 信达证券基金 ...

Core Viewpoint - The major shareholder, Wukuang Jintong Equity Investment Fund Management Co., Ltd., and its concerted action party plan to reduce their holdings in New Mile Health Technology Group Co., Ltd. by up to 67,747,635 shares, representing 2% of the total share capital, within a three-month period starting from May 23, 2025 [1] Group 1: Shareholding Changes - Wukuang Jintong and its concerted action party reduced their holdings by 22,387,200 shares from July 14 to July 31, 2025, which is 0.6609% of the total share capital [2] - After the reduction, Wukuang Jintong holds 174,862,123 shares and Shenzhen Tongzhikang holds 62,250,677 shares, totaling 237,112,800 shares, which is 6.9999% of the total share capital [2] - The total shares held by Wukuang Jintong decreased from 259,500,000 shares (7.6608%) to 237,112,800 shares (6.9999%) [2] Group 2: Compliance and Legal Matters - The shareholding change does not violate any laws, regulations, or rules related to securities and corporate governance [3] - There are no shares that are restricted from voting rights according to the Securities Law [3]

Group 1 - The core point of the article is that Wuzhong Jintong Equity Investment Fund Management Co., Ltd. and its concerted actions plan to reduce their shareholding in the company by a total of 22.3872 million shares, which represents 0.66% of the company's total share capital [1] - After the reduction, the total shares held by the two parties will be 23.7128 million shares, decreasing their ownership stake to 6.9999% of the company's total share capital [1]

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2025-044 新里程健康科技集团股份有限公司 关于持股 5%以上股东权益变动触及 1%整数倍的公告 股东五矿金通股权投资基金管理有限公司－金通健康产业 1 号私募股权投资 基金及其一致行动人五矿金通股权投资基金管理有限公司－深圳通芝康健康产 业投资企业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）于 2025 年 4 月 28 日披露了《关于持股 5%以上股东拟减持股份的预披露公告》（公 告编号：2025-010）。公司股东五矿金通股权投资基金管理有限公司－金通健康 产业 1 号私募股权投资基金（以下简称"五矿-金通健"）及其一致行动人五矿 金通股权投资基金管理有限公司－深圳通芝康健康产业投资企业（有限合伙）（以 下简称"五矿-通芝康"）拟在该公告披露日起十五个交易日后的三个月内（即 2025 年 5 月 23 日至 2025 年 8 月 22 ...